Efficacy of emollient, anti-inflammatory cream contining Isoleucine vs. standard emollient cream in children with facial atopic dermatitis

Efficacy of emollient, anti-inflammatory cream contining Isoleucine vs. standard emollient cream in children with facial atopic dermatitis (AD) with evaluation of facial EASI score

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON21723

Enrollment

Registered

2013-07-21

Start date

2013-09-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atopic dermatitis of the face in children

Interventions

Cream containing rhamnosoft, niacinamide and Isoleucine Standard emollient cream (glycerol)

Eligibility

Inclusion criteria

Inclusion criteria: Children aged 1-12 years Atopic Dermatitis mild to moderate Presence of lesions on the Face

Exclusion criteria

Exclusion criteria: Severe AD Treatment with systemic anti-inflammatory drugs

Design outcomes

Primary

Measure	Time frame
EASI score (eczema, itch, infiltration,escoriation)	—

Secondary

Measure	Time frame
Investigator global assessement	—

Contacts

Public ContactMassimo Milani

Via Nota 18

masmilan2000@yahoo.it0039026431247

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)